Difficulty: Medium
Average Score: 74%
Practice
Exposure to which illness should be a cause to discontinue therapy and substitute dipyridamole (Persantine) in a child receiving aspirin therapy for Kawasaki disease (KD)?
Correct answer
A
Rationale
In the case of a child receiving aspirin therapy for Kawasaki disease (KD), exposure to chickenpox or influenza should be a cause to discontinue therapy and substitute dipyridamole (Persantine). This is because aspirin therapy in the presence of a viral infection like chickenpox or influenza can increase the risk of Reye's syndrome, a rare but serious condition that affects the liver and brain.
Option A is correct because both chickenpox and influenza are viral infections that can increase the risk of Reye's syndrome when aspirin is used concurrently.
Option B (E. coli or staphylococcus) and Option D (Streptococcus A or staphylococcus) are incorrect as these bacterial infections do not pose the same risk in relation to aspirin therapy in KD.
Option C (Mumps or streptococcus A) is also incorrect as mumps is a viral infection that, like chickenpox and influenza, can increase the risk of Reye's syndrome with aspirin therapy.
Educationally, it is crucial for healthcare providers to be aware of the potential complications and interactions that can arise in pediatric pharmacotherapy, especially in conditions like KD where aspirin is a key component of treatment. Understanding the specific contraindications and risks associated with different infections and medications is essential for safe and effective patient care.
Option A is correct because both chickenpox and influenza are viral infections that can increase the risk of Reye's syndrome when aspirin is used concurrently.
Option B (E. coli or staphylococcus) and Option D (Streptococcus A or staphylococcus) are incorrect as these bacterial infections do not pose the same risk in relation to aspirin therapy in KD.
Option C (Mumps or streptococcus A) is also incorrect as mumps is a viral infection that, like chickenpox and influenza, can increase the risk of Reye's syndrome with aspirin therapy.
Educationally, it is crucial for healthcare providers to be aware of the potential complications and interactions that can arise in pediatric pharmacotherapy, especially in conditions like KD where aspirin is a key component of treatment. Understanding the specific contraindications and risks associated with different infections and medications is essential for safe and effective patient care.